Ventum Cap Mkts upgraded shares of Centric Health (TSE:CRX – Free Report) to a strong-buy rating in a report issued on Thursday, Zacks.com reports.
Centric Health Price Performance
Centric Health (TSE:CRX – Get Free Report) last announced its quarterly earnings data on Friday, May 10th. The company reported C($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of C($0.02) by C$0.01. The firm had revenue of C$89.73 million during the quarter, compared to analysts’ expectations of C$89.80 million.
Featured Stories
- Five stocks we like better than Centric Health
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Wall Street Analysts Raised Price Targets for Suncor Stock
- What is Forex and How Does it Work?
- Is Super Micro Computer a Buy After Shares Sink 20% on Earnings?
- How Can Investors Benefit From After-Hours Trading
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
